February 2017

COVID-19 Vaccine in Children With Disabilities and Complex Healthcare Needs

Author: Dr. Kathleen Muldoon & Dr. Megan Pesch The kid-sized Pfizer-BioNTech COVID-19 vaccine was recently authorized for children 5 to 11 years of age. 28 million children are now eligible for vaccination, including approximately 1 in 6 children with a developmental disability. [1]  Recent statistics show why pediatricians and infectious disease experts at the National CMV Foundation support the vaccine for younger children, including for children with disabilities.

2017 CMV Legislation Proposed in Four States

What do Idaho, Iowa, Oregon, and Maine have in common? These states have proposed state CMV legislation for 2017! Thanks to the hard work of sponsors, parents, physicians, and other advocates within these states, CMV legislation with proposed education and/or screening programs will be evaluated during this legislative session in each individual state. So what's in all of these bills? Check out our blog for summaries and links to bill text and updates. 

​Microcephaly 101

Microcephaly has been making headlines over the last year as potential brain malformation connected to women diagnosed with Zika during pregnancy. However, kids are at risk of being born with microcephaly even in areas of the world not hit by the Zika virus. Many of these cases are caused by cytomegalovirus, or CMV. Unlike Zika, which is only being actively transmitted in a small area of the world, CMV exists virtually everywhere. To reduce these cases, we need to increase awareness of CMV: causes, detection, treatments, etc.